SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 19, 2010
BioMedical Technology Solutions Holdings, Inc.
(Exact name of registrant as specified in its charter)
| | |
Colorado | 000-52652 | 26-3161860 |
(State or other jurisdiction of incorporation or organization) | (Commission file number) | (IRS Employer Identification No.) |
9800 Mt Pyramid Court # 250
Englewood, CO 80112
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 653-0100
_ ____________________________
(Former name or former address, if changed since last report)
| |
___ | Written communications pursuant to Rule 425 under the Securities Act |
___ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
___ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
| |
ITEM 5.02 | DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS. |
Effective July 19, 2010, David A. Kempf voluntarily tendered his resignation as a Director of BioMedical Technology Solutions Holdings, Inc. The resignation was effective immediately.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| | | BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC.
|
Date: July 19, 2010 | By: __/s/ Donald G. Cox_________ Donald G. Cox, President |
| | |
2
